T-stat
NDC Package 0072-8300-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

T-stat is a . Marketed by Bristol-myers Squibb Pharma Company, this product is identified by NDC 0072-8300 and is authorized under FDA application ANDA062436.

Identification & Billing

NDC Package Code
0072-8300-60
Package Description
60 mL in 1 BOTTLE, WITH APPLICATOR
Product Code
0072-8300
11-Digit Billing Format
00072830060

Clinical Specifications

Proprietary Name
T-stat
Dosage Form
-

Regulatory & Marketing

Labeler Name
Bristol-myers Squibb Pharma Company
FDA Application #
ANDA062436
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-30-1997
End Marketing Date
03-16-2006
Listing Expiration
03-16-2006
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0072-8300-60 identifies a specific commercial package of 60 ml in 1 bottle, with applicator of T-stat, labeled by Bristol-myers Squibb Pharma Company. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Bristol-myers Squibb Pharma Company on September 30, 1997. The current certification is valid through March 16, 2006.

How is this Bristol-myers Squibb Pharma Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00072830060. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0072-8300-60
11-Digit CMS (5-4-2)
00072-8300-60

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.